Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass grafting  Herman Kroneman, MD, Bert.

Similar presentations


Presentation on theme: "Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass grafting  Herman Kroneman, MD, Bert."— Presentation transcript:

1 Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass grafting  Herman Kroneman, MD, Bert C. Eikelboom, MD, E.A.R. Knot, MD, Pìet de Smit, MD, Theo H.N. Groenland, MD, Moniek P.M. de Maat, Hero Van Urk, MD  Journal of Vascular Surgery  Volume 14, Issue 2, Pages (August 1991) DOI: /mva Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

2 Fig. 1 The anti-factor Xa activity (IU/ml) before heparin (BH) and after heparin administration in patients receiving UFH or LMWH (mean ± SD). The arrow indicates an increase of UFH concentration after flushing of the aorta with UFH preparations. Journal of Vascular Surgery  , DOI: ( /mva ) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions

3 Fig. 2 Intraoperative FbDP plasma levels (μg/ml) before heparin administration and at the end of operation (mean ± SD). Journal of Vascular Surgery  , DOI: ( /mva ) Copyright © 1991 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter Terms and Conditions


Download ppt "Pharmacokinetics of low-molecular-weight heparin and unfractionated heparin during elective aortobifemoral bypass grafting  Herman Kroneman, MD, Bert."

Similar presentations


Ads by Google